CDK-IN-14
Product Specifications
Target
CDK, Apoptosis, Caspase
Related Pathways
Apoptosis, Proteases/Proteasome, Cell Cycle/Checkpoint
Bioactivity
CDK-IN-14 (B34) is a CDK2 inhibitor (IC50=0.097 μM) that exhibits anti-hepatocellular carcinoma activity. It inhibits the cell cycle in HepG-2 cancer cells and induces apoptosis (apoptosis) through a caspase-mediated mechanism.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-PCSK1-Ra-96Tests 96 Tests
Rat Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) ELISA Kit
Sign In for Pricing
View Details MBS6413786-01 0.1 mL
DDIT3 (DNA Damage-inducible Transcript 3 Protein, C/EBP-homologous Protein 10, CEBPZ, CHOP, CHOP10, GADD153, MGC4154) (MaxLight 490)
Sign In for Pricing
View Details MBS6413786-02 5x 0.1 mL
DDIT3 (DNA Damage-inducible Transcript 3 Protein, C/EBP-homologous Protein 10, CEBPZ, CHOP, CHOP10, GADD153, MGC4154) (MaxLight 490)
Sign In for Pricing
View Details 
AZQ90Z46-Fluoro550 100 µg/Vial
Anti-Zebrafish SOX32 Antibody Picoband® Fluoro550 Conjugated
Sign In for Pricing
View Details